Colorectal Cancer: National and International Perspective on the Burden of Disease and Public Health Impact

Gastroenterology

Volumn 138, Issue 6, 2010, Pages 2177-2190

  Gellad, Ziad F ^a   Provenzale, Dawn ^a  

^a DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Colorectal Neoplasm; Healthcare Disparities; Public Health; Screening

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; ETHNIC DIFFERENCE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH DISPARITY; HIGH RISK POPULATION; HUMAN; OCCULT BLOOD; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; RACE DIFFERENCE; SEX RATIO; SOCIOECONOMICS; SURVIVAL RATE; SURVIVAL TIME; UNITED STATES;

EID: 77951625831     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.01.056     Document Type: Article

References (103)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 59 (2009) 225-249
2. American Cancer Society. Colorectal cancer facts & figures 2008-2010 (2008), American Cancer Society, Atlanta, GA
3. Brown M.L., Klabunde C.N., and Mysliwiec P. Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices. Am J Med 115 (2003) 129-133
4. Seeff L.C., Manninen D.L., Dong F.B., et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?. Gastroenterology 127 (2004) 1661
5. National Cancer Institute. SEER cancer statistics review, 1975-2006 (2009). http://seer.cancer.gov/csr/1975_2006/ Accessed September 25, 2009
6. NCCN clinical practice guidelines in oncology: colon cancer (2009). www.nccn.org Accessed September 25, 2009
7. State cancer profiles: death rate report by state, death years through 2006 (2009). http://statecancerprofiles.cancer.gov Accessed December 11, 2009
8. National Cancer Institute. Cancer trends progress report-2007 update (December 2007), National Cancer Institute, Bethesda, MD. http://progressreport.cancer.gov
9. Yabroff K.R.P., Warren J.L.P., Banthin J.P., et al. Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?. Med Care 47 Suppl 1 (2009) S64-S69
10. Yabroff K.R., Mariotto A.B., Feuer E., et al. Projections of the costs associated with colorectal cancer care in the United States, 2000-2020. Health Econ 17 (2008) 947-959
11. Sonnenberg A., Delco F., and Inadomi J.M. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 133 (2000) 573-584
12. Yabroff K.R., Warren J.L., Schrag D., et al. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients. Med Care 47 (2009) S56-S63
13. Lang K., Lines L.M., Lee D.W., et al. Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data. Clin Gastroenterol Hepatol 7 (2009) 198-204
14. State cancer profiles: incidence rate report by state through 2006 (2009). http://statecancerprofiles.cancer.gov Accessed December 11, 2009
15. Use of colorectal cancer tests-United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep 57 (2008) 253-258
16. Agrawal S., Bhupinderjit A., Bhutani M.S., et al. Colorectal cancer in African Americans. Am J Gastroenterol 100 (2005) 515-523 discussion 524
17. Yan B., Noone A.M., Yee C., et al. Racial differences in colorectal cancer survival in the Detroit Metropolitan Area. Cancer 115 (2009) 3791-3800
18. Du X.L., Meyer T.E., and Franzini L. Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer. Cancer 109 (2007) 2161-2170
19. Doubeni C.A., Field T.S., Buist D.S.M., et al. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer 109 (2007) 612-620
20. Rim S.H., Seeff L., Ahmed F., et al. Colorectal cancer incidence in the United States, 1999-2004. Cancer 115 (2009) 1967-1976
21. Wong M.D., Ettner S.L., Boscardin W.J., et al. The contribution of cancer incidence, stage at diagnosis and survival to racial differences in years of life expectancy. J Gen Intern Med 24 (2009) 475-481
22. Espey D.K., Wu X.C., Swan J., et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer 110 (2007) 2119-2152
23. Jemal A., Thun M.J., Ries L.A., et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 100 (2008) 1672-1694
24. Polite B.N., Dignam J.J., and Olopade O.I. Colorectal cancer model of health disparities: understanding mortality differences in minority populations. J Clin Oncol 24 (2006) 2179-2187
25. Bach P.B., Schrag D., Brawley O.W., et al. Survival of blacks and whites after a cancer diagnosis. JAMA 287 (2002) 2106-2113
26. Trivers K.F., Shaw K.M., Sabatino S.A., et al. Trends in colorectal cancer screening disparities in people aged 50-64 years, 2000-2005. Am J Prev Med 35 (2008) 185-193
27. Cooper G.S., and Koroukian S.M. Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer 100 (2004) 418-424
28. Hayanga A.J., Waljee A.K., Kaiser H.E., et al. Racial clustering and access to colorectal surgeons, gastroenterologists, and radiation oncologists by African Americans and Asian Americans in the United States: a county-level data analysis. Arch Surg 144 (2009) 532-535
29. Baldwin L.-M., Dobie S.A., Billingsley K., et al. Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst 97 (2005) 1211-1220
30. White A., Liu C.C., Xia R., et al. Racial disparities and treatment trends in a large cohort of elderly African Americans and Caucasians with colorectal cancer, 1991 to 2002. Cancer 113 (2008) 3400-3409
31. Dominitz J.A., Samsa G.P., Landsman P., et al. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer 82 (1998) 2312-2320
32. Rabeneck L., Souchek J., and El-Serag H.B. Survival of colorectal cancer patients hospitalized in the Veterans Affairs health care system. Am J Gastroenterol 98 (2003) 1186-1192
33. Emmons K.M., Lobb R., Puleo E., et al. Colorectal cancer screening: prevalence among low-income groups with health insurance. Health Aff 28 (2009) 169-177
34. Le H., Ziogas A., Lipkin S.M., et al. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol Biomarkers Prev 17 (2008) 1950-1962
35. Byers T.E., Wolf H.J., Bauer K.R., et al. The impact of socioeconomic status on survival after cancer in the United States. Cancer 113 (2008) 582-591
36. Shapiro J.A., Seeff L.C., Thompson T.D., et al. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 17 (2008) 1623-1630
37. Cancer facts and figures (2008), American Cancer Society, Atlanta, GA
38. Atkins D. First new screening recommendations from the third US Preventive Services Task Force. BMJ 327 (2003) E21-E24
39. Mandel J.S., Bond J.H., and Church T.R. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 328 (1993) 1365-1371
40. Hardcastle J.D., Chamberlain J.O., Robinson M.H., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348 (1996) 1472-1477
41. Kronborg O., Fenger C., and Jorn O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348 (1996) 1467-1471
42. Screening for colorectal cancer-United States, 1997. MMWR Morb Mortal Wkly Rep 48 (1999) 116-121
43. Schenck A.P., Peacock S.C., Klabunde C.N., et al. Trends in colorectal cancer test use in the Medicare population, 1998-2005. Am J Prev Med 37 (2009) 1-7
44. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 149 (2008) 627-637
45. Levin B., Lieberman D.A., McFarland B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134 (2008) 1570-1595
46. El-Serag H.B., Petersen L., Hampel H., et al. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs. Arch Intern Med 166 (2006) 2202-2208
47. Fisher D.A., Judd L., and Sanford N. Inappropriate colorectal cancer screenings: findings and implications. Am J Gastroenterol 100 (2005) 2526-2530
48. Pignone M., Saha S., Hoerger T., et al. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 137 (2002) 96-104
49. Provenzale D. Cost-effectiveness of screening the average-risk population for colorectal cancer. Gastrointest Endosc Clin North Am 12 (2002) 93-109
50. Lansdorp-Vogelaar I., van Ballegooijen M., Zauber A.G., et al. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst 101 (2009) 1412-1422
51. Subramanian S., Klosterman M., Amonkar M.M., et al. Adherence with colorectal cancer screening guidelines: a review. Prev Med 38 (2004) 536-550
52. Rapuri S., Spencer J., and Eckels D. Importance of postpolypectomy surveillance and postpolypectomy compliance to follow-up screening-review of literature. Int J Colorectal Dis 23 (2008) 453-459
53. Wei E.K., Colditz G.A., Giovannucci E.L., et al. Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses' Health Study. Am J Epidemiol 170 (2009) 863-872
54. Newcomb P.A., Storer B.E., Morimoto L.M., et al. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst 95 (2003) 622-625
55. Selby J.V., Friedman G.D., Quesenberry Jr. C.P., et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326 (1992) 653-657
56. Hoff G., Grotmol T., Skovlund E., et al., Norwegian Colorectal Cancer Prevention Study Group. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 338 (2009) b1846
57. Gross C.P., Andersen M.S., Krumholz H.M., et al. Relation between medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA 296 (2006) 2815-2822
58. Brenner H., Hoffmeister M., Brenner G., et al. Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies. Eur J Cancer 45 (2009) 2027-2033
59. Kahi C.J., Imperiale T.F., Juliar B.E., et al. Effect of screening colonoscopy on colorectal cancer incidence. Clin Gastroenterol Hepatol 7 (2009) 770-775
60. Baxter N.N., Goldwasser M.A., Paszat L.F., et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 150 (2009) 1-8
61. Bressler B., Paszat L.F., Chen Z., et al. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology 132 (2007) 96-102
62. Gorski T.F., Rosen L., Riether R., et al. Colorectal cancer after surveillance colonoscopy: false-negative examination or fast growth?. Dis Colon Rectum 42 (1999) 877-880
63. Farrar W.D., Sawhney M.S., Nelson D.B., et al. Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hepatol 4 (2006) 1259-1264
64. Hosokawa O., Shirasaki S., Kaizaki Y., et al. Invasive colorectal cancer detected up to 3 years after a colonoscopy negative for cancer. Endoscopy 35 (2003) 506-510
65. Lakoff J., Paszat L.F., Saskin R., et al. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol 6 (2008) 1117-1121
66. Rabeneck L., Paszat L.F., and Saskin R. Endoscopist specialty is associated with incident colorectal cancer after a negative colonoscopy. Clin Gastroenterol Hepatol 8 (2010) 275-279
67. Brenner H., Hoffmeister M., Arndt V., et al. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 102 (2010) 89-95
68. Hewett D.G., Kahi C.J., and Rex D.K. Does colonoscopy work?. J Natl Compr Cancer Netw 8 (2010) 67-76
69. Robertson D.J., Greenberg E.R., Beach M., et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 129 (2005) 34-41
70. Martinez M.E., Sampliner R., Marshall J.R., et al. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology 120 (2001) 1077-1083
71. Lieberman D. A call to action-measuring the quality of colonoscopy. N Engl J Med 355 (2006) 2588-2589
72. Henry S.G., Ness R.M., Stiles R.A., et al. A cost analysis of colonoscopy using microcosting and time-and-motion techniques. J Gen Intern Med 22 (2007) 1415-1421
73. Centers for Medicare & Medicaid Services. 2009 Physician Quality Reporting Initiative. http://www.cms.hhs.gov/PQRI/Downloads/2009_PQRI_MeasuresList_030409.pdf Accessed September 28, 2009
74. Federal Register. Department of Health and Human Services Medicare Program: payment policies under the physician fee schedule and other revisions to Part B for CY 2010. http://www.cms.hhs.gov/PQRI/Downloads/CMS_1413_P.pdf Accessed September 28, 2009
75. Lieberman D., Nadel M., Smith R.A., et al. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc 65 (2007) 757-766
76. Lieberman D.A., Faigel D.O., Logan J.R., et al. Assessment of the quality of colonoscopy reports: results from a multicenter consortium. Gastrointest Endosc 69 (2009) 645-653
77. Barclay R.L., Vicari J.J., Doughty A.S., et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 355 (2006) 2533-2541
78. Rex D.K. Colonoscopic withdrawal technique is associated with adenoma miss rates. Gastrointest Endosc 51 (2000) 33-36
79. Imperiale T.F., Glowinski E.A., Juliar B.E., et al. Variation in polyp detection rates at screening colonoscopy. Gastrointest Endosc 69 (2009) 1288-1295
80. Simmons D.T., Harewood G.C., Baron T.H., et al. Impact of endoscopist withdrawal speed on polyp yield: implications for optimal colonoscopy withdrawal time. Aliment Pharmacol Ther 24 (2006) 965-971
81. Mysliwiec P.A., Brown M.L., Klabunde C.N., et al. Are physicians doing too much colonoscopy?. A national survey of colorectal surveillance after polypectomy. Ann Intern Med 141 (2004) 264-271
82. Saini S., Nayak R.S., Kuhn L., et al. Why don't gastroenterologists follow colon polyp surveillance guidelines?. Results of a national survey. J Clin Gastroenterol 43 (2009) 554-558
83. Donabedian A. Evaluating the quality of medical care. Milbank Q 44 (1966) 166-203
84. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
85. Ferlay J., Autier P., Boniol M., et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18 (2007) 581-592
86. Center M.M., Jemal A., and Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 18 (2009) 1688-1694
87. Global cancer facts & figures (2007), American Cancer Society, Atlanta, GA
88. Coleman M.P., Quaresma M., Berrino F., et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 9 (2008) 730-756
89. Gatta G., Ciccolallo L., Capocaccia R., et al. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer 39 (2003) 2214-2222
90. Madlensky L., Goel V., Polzer J., et al. Assessing the evidence for organised cancer screening programmes. Eur J Cancer 39 (2003) 1648-1653
91. Lambert R., Sauvaget C., and Sankaranarayanan R. Mass screening for colorectal cancer is not justified in most developing countries. Int J Cancer 125 (2009) 253-256
92. Benson V.S., Patnick J., Davies A.K., et al. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer 122 (2008) 1357-1367
93. Gutierrez-Ibarluzea I., Asua J., and Latorre K. Policies of screening for colorectal cancer in European countries. Int J Technol Assess Health Care 24 (2008) 270-276
94. National Cancer Institute. Inventory of colorectal cancer screening activities in ICSN countries, May 2008. http://appliedresearch.cancer.gov/icsn/colorectal/screening.html Accessed August 29, 2009
95. Recommendations on cancer screening in the European Union. Eur J Cancer 36 (2000) 1473-1478
96. Regula J., Rupinski M., Kraszewska E., et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 355 (2006) 1863-1872
97. West N.J., Boustiere C., Fischbach W., et al. Colorectal cancer screening in Europe: differences in approach; similar barriers to overcome. Int J Colorectal Dis 24 (2009) 731-740
98. McGregor S.E., Hilsden R.J., Li F.X., et al. Low uptake of colorectal cancer screening 3 yr after release of national recommendations for screening. Am J Gastroenterol 102 (2007) 1727-1735
99. Rabeneck L., and Paszat L.F. A population-based estimate of the extent of colorectal cancer screening in Ontario. Am J Gastroenterol 99 (2004) 1141-1144
100. Maciosek M.V., Solberg L.I., Coffield A.B., et al. Colorectal cancer screening: health impact and cost effectiveness. Am J Prev Med 31 (2006) 80-89
101. Moayyedi P., Tepper J., Hilsden R., et al. International comparisons of manpower in gastroenterology. Am J Gastroenterol 102 (2007) 478-481
102. Levi Z., Chorev N., Segal N., et al. Screening for colorectal cancer in personnel of an academic medical center. Dig Dis Sci 52 (2007) 2301-2304
103. Regula J., Zagorowicz E., and Butruk E. Implementation of a national colorectal cancer screening program. Curr Colorectal Cancer Rep 2 (2007) 25-29